Cerep Raises $11 Mil. In France; Seattle In Vitro Tox Facility Planned
Executive Summary
The French combinatorial chemistry/screening company Cerep is establishing a U.S. facility to perform in vitro predictive testing of absorption, metabolism and toxicology as part of the company's expansion activities following an $11 mil. infusion of capital from a European stock placement.